James F. Young, Director at NOVAVAX INC (NVAX), sold 175,000 shares at $1.06 ($186K) on 2017-08-31, disclosed to the SEC on 2017-09-01.
Open-market sale of $186k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |